SCPH

4.07

0.99% 0.04

Handel nachbörslich: 4.07

Scpharmaceuticals Inc (SCPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$4.03

Offen:

$4.02

24-Stunden-Volumen:

94,078

Relative Volume:

0.31

Marktkapitalisierung:

$203.12M

Einnahmen:

$17.63M

Nettoeinkommen (Verlust:

$-57.71M

KGV:

-3.0602

EPS:

-1.33

Netto-Cashflow:

$-60.45M

1W Leistung:

-8.13%

1M Leistung:

-4.91%

6M Leistung:

-12.66%

1J Leistung:

-24.07%

1-Tages-Spanne:

$4.02

$4.08

1-Wochen-Bereich:

$4.00

$4.60

52-Wochen-Spanne:

$3.24

$6.71

Scpharmaceuticals Inc Stock (SCPH) Company Profile

Firmenname

Scpharmaceuticals Inc

Sektor

Healthcare (1182)

Branche

Biotechnology (671)

Telefon

617-517-0730

Adresse

25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA

Mitarbeiter

Twitter

@scPharmaUSA

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

SCPH's Discussions on Twitter

Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-12-01	Eingeleitet	Cowen	Outperform
2022-10-21	Fortgesetzt	Jefferies	Buy
2022-10-11	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-08-02	Eingeleitet	Maxim Group	Buy
2021-09-09	Eingeleitet	SVB Leerink	Mkt Perform
2019-10-15	Eingeleitet	H.C. Wainwright	Buy
2019-01-30	Herabstufung	Leerink Partners	Outperform → Mkt Perform

Alle ansehen

Scpharmaceuticals Inc Aktie (SCPH) Neueste Nachrichten

Nov 02, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat

Nov 02, 2024

Nov 01, 2024

KING LUTHER CAPITAL MANAGEMENT CORP Expands Stake in scPharmaceu - GuruFocus.com

Nov 01, 2024

Oct 23, 2024

TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval - Investing.com India

Oct 23, 2024

TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval By Investing.com - Investing.com South Africa

Oct 23, 2024

Oct 21, 2024

Third Time's The Charm For ScPharma? - RTTNews

Oct 21, 2024

Oct 15, 2024

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024 - GlobeNewswire

Oct 15, 2024

Congestive Heart Failure Treatment Market 2034: Clinical - openPR

Oct 15, 2024

Oct 09, 2024

The Attractiveness of Investing In scPharmaceuticals Inc (SCPH) is Growing - Knox Daily

Oct 09, 2024

Daily Progress: scPharmaceuticals Inc (SCPH) Drop -2.33, Closing at 3.97 - The Dwinnex

Oct 09, 2024

Oct 08, 2024

scPharmaceuticals GAAP EPS of -$0.41 misses by $0.05, revenue of $3.8M beats by $0.38M - MSN

Oct 08, 2024

Oct 07, 2024

Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect? - MSN

Oct 07, 2024

Oct 05, 2024

351,806 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Acquired by Bank of Montreal Can - MarketBeat

Oct 05, 2024

Sep 28, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Short Interest Down 15.0% in September - MarketBeat

Sep 28, 2024

Sep 23, 2024

Holdings of scPharmaceuticals Inc (SCPH) are aligned with the stars - SETE News

Sep 23, 2024

Craig Hallum gives a Buy recommendation for scPharmaceuticals Inc (SCPH) - Knox Daily

Sep 23, 2024

Sep 21, 2024

King Luther Capital Management Corp Purchases 752,005 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Sep 21, 2024

Sep 16, 2024

Investors in scPharmaceuticals (NASDAQ:SCPH) have unfortunately lost 23% over the last year - Yahoo Finance

Sep 16, 2024

Sep 12, 2024

Rice Hall James & Associates LLC Has $2.16 Million Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Sep 12, 2024

Sep 11, 2024